Evotec is participating in the €8 million ($8.46 million) Series A of its current partner in developing metabolic disease therapy Eternygen.

INC Research is planning to move its headquarters to a nearby site in North Carolina, invest $38 million for 550 new jobs over the next five years.

Rumors that PPD’s owners intend to sell the CRO refuse to die, with reports emerging once again that it is on the block for about $5 billion.

The clinical trial management system market will show double-digit growth, reaching $1.85 billion by 2019, and will be integrated more closely with healthcare…

Carrying out contract clinical research for life science companies injects around £192 million into the U.K. National Health Service every year in income and…

Medpace saw net service revenue hit $94.8 million for Q3, a jump of 16.1% compared to last year, as it enjoys life after its $160 million summer IPO.

In its first quarter after the merger of Quintiles and IMS Health, the newly formed single company said it has kick-started a $1.5 billion repurchase of…

Major CRO INC has beaten out Wall Street expectations after posting a jump in revenue for the past three months.

CROs can look forward to “steady but tentative growth” in the coming years, but the biggest gainers will be the largest companies in the business, with the…

Financials